Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Reda Mohamed

Reda Mohamed

Benha University Egypt

Sophia Chew

Sophia Chew

General Hospital Singapore

Wajih Maazouzi

Wajih Maazouzi

University Medical Center of Rabat Morocco

Rainer G. H. Moosdorf

Rainer G. H. Moosdorf

University Hospital of Giessen and Marburg GmbH Germany Germany

Kevin A. Courville

Kevin A. Courville

Prevail Heart Clinics USA

Heinz-Peter Schultheiss

Heinz-Peter Schultheiss

Institute of Cardiac and Diagnostic Therapy Germany

Jochen Senges

Jochen Senges

Stiftung Institut für Herzinfarktforschung Ludwigshafen Germany

Nattapong Thaiyanurak

Nattapong Thaiyanurak

Siriraj Hospital-Mahidol University Thailand

Euro Cardiology Congress 2023

About Conference

Euro Cardiology Congress 2023 with a goal to empower healthcare providers welcomes all the professionals from Medical Healthcare, Cardiologists, Surgeons, Medicine Specialists, Professors, Medical Researchers, Nurses and Nurse Practitioners, Fellow Scholars, Industrial Professionals, Physicians and Student Delegates to our two-day event “4th European Cardiology Congress” scheduled on May 22-23, 2023 London, UK .

 Euro Cardiology Congress 2023 with the theme Promoting the new innovative thoughts in Cardiac Research will be featuring the world class keynote talk, speakers presenting clinical studies, oral and poster presentation with interactive networking session and workshops.

The main objective of Conference is to provide a platform for all the medical professionals including students to discuss and learn the new innovations on cardiology research, clinical updates and new discoveries with the cardiology and industrial experts to advance the ongoing research. The conference will highlight on Cardiac Surgery and Heart Failure, Cardio-Oncology and Resources, Congenital Heart Disease and Pediatric Cardiology, Diabetes and Cardio metabolic Disease, Advanced Lipid Testing, Geriatric Cardiology, Cardiomyopathies, Acute, chronic Heart Failure and Heart Transplant, Interventions and Coronary Artery Disease, Structural Heart Disease, Pulmonary Hypertension, Peripheral Vascular, Noninvasive Imaging, prevention, Sports and Exercise Cardiology, clinical updates, case reports.

Euro Cardiology Congress-2023 pact with an assembly course of 1000+ Global Events, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia and circulates 700+ Open Access journals which contains more than 30000 unique personalities, reputed specialists as article board people.

Why to Attend?

Euro Cardiology Congress- 2023 is among the World's leading Scientific Conference to bring together worldwide distinguished healthcare experts in the field of cardiology, researchers, public health professionals, professors, academic scientists, industry researchers, scholars to exchange their ideas. You can take the opportunities of lectures from industry leaders, session on hot topics, interaction with company’s representatives, Meeting delegates and interaction over lunch and coffee breaks. The objective of this meeting is to stimulate new ideas for treatment and analyze the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with a greater prominence on newer products that will be beneficial across the spectrum of Cardiology. We expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Symposium hosting (4-5-member team)

Workshop organizing

For Universities, Associations & Societies:

Association Partnering

Collaboration proposals

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)

Young Researcher Forum (YRF Award to the best presenter)

Student Attendee

Group registrations

For Business Delegates:

Speaker Presentations

Symposium hosting

Book Launch event

Networking opportunities

Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths

Sponsorships opportunities

Product launch       

Workshop organizing

Scientific Partnering




Sessions /Tracks

Track 1: Congenital Heart Disease and Pediatrics

Congenital Heart disease and pediatrics Congenital heart defect, it means that children born with a problem in the structure of his or her heart. Some congenital heart defects in children are simple and don't need treatment. Other congenital heart defects in children are more complex and may require several surgeries performed over a period of several years. There are many different types of congenital heart defects:

  • Holes in the heart
  • Obstructed blood flow
  • Abnormal blood vessels
  • Heart valve abnormalities
  • An underdeveloped heart
  • A combination of defects

Cardiologists, cardiac surgeons and pediatric cardiovascular specialists are welcome to share their experience and research to advance the cutting-edge diagnostic and surgical techniques.

  • Atrial Septal Defect
  • Atrioventricular Canal Defect
  • Ebstein’s Anomaly
  • Hypoplastic Left Heart Syndrome
  • Interrupted Aortic Arch
  • Pulmonary Stenosis and Atresia
  • Transposition of the Great Arteries
  • Ventricular Septal Defect

Track 2: Cardiovascular Disease, Risk factors and Nutrition

Cardiovascular disease (CVD) is the leading cause of death in many developed countries and remains one of the major diseases strongly affected by the diet. Nutrition can affect CVD directly by contributing to the accumulation of vascular plaques and indirectly by regulating the rate of aging. Consumption of ultra-processed foods worldwide study found that eating more plant-based foods reduces the risk of heart failure by 40%, while another one has increased substantially, studies have shown that higher consumption of ultra-processed foods was associated with higher risks of cardiovascular, coronary heart, and cerebrovascular diseases. Recent found that a vegetarian diet cuts the risk of heart disease death.

Researchers are welcome to present their observation and advice which can reduce risk and preventive factors in the development and prevention of CVD.

  • Atherosclerosis and Hypertension affected by diet
  • Nutrients and their impact on cardiovascular disease
  • Dietary Cholesterol intake
  • Obesity associated with cardiovascular disease

Track 3: Cardiac Imaging

Cardiac imaging Scientific, educational and CVI professionals including cardiologists, cardiovascular radiologists, sonographers, imaging cardiologists, nuclear medicine physicians, pulmonologists, internists, cardiothoracic surgeons, pathologists and nurses are pleased to contribute their knowledge and research to promote and develop advance research and clinical practice of Cardiovascular Imaging, helping to improve the standardization of CVI practice.

It includes magnetic resonance imaging, computed tomography, X-ray imaging, interventional imaging, applications in nuclear cardiology and echocardiography, and any combination of these techniques. Clinical applications of such imaging techniques include improved diagnostic approaches, treatment and prognosis.

  • Echocardiography
  • Magnetic resonance imaging (MRI)
  • Computed tomography (CT)
  • Nuclear medicine imaging
  • Coronary catheterization
  • Intravascular ultrasound

Track 4:  Valvular  Heart Disease

Valvular Heart Disease  is now at the center of developments in Cardiovascular Medicine and Surgery, it is a pathological condition affecting one or more of the heart valves, elevated blood pressure is a well-known risk factor. In valvular heart disease, we don’t really have treatment outside of changing the valves, or repairing the valves, which is very expensive and too late in the disease process.

So, individuals involved in the research who wish to present their observation are welcome to help understand the future developments and ideas to prevent this from happening.

  • Aortic and mitral valve disorders
  • Pulmonary and tricuspid valve disorders
  • Calcific disease
  • Dysplasia
  • Aortic stenosis and Mitral stenosis

Track 5:  Coronary Heart Diseases

Coronary heart diseases Also known as coronary artery disease, one of the leading causes of death worldwide, forms plaque in the walls of the arteries that supply blood to the heart. A complete blockage of these arteries can lead to a heart attack or stroke. Further, studies have shown that many genes contributing to the genetics of coronary artery disease affect mechanisms that were not expected. Join us with your group to explore the novel insights on how to prevent its development. Also know:

  • Pathophysiology of Coronary Artery Disease
  • Coronary Artery Disease Angina
  • Coronary Artery Disease Risk Factors, Preventions and Treatment
  • Coronary Artery Disease and Omega-3 Fatty Acids
  • Pathophysiology- lack of oxygen
  • Risk factors of coronary heart disease
  • Effective lifestyle- Secondary prevention
  • New treatment options for coronary artery disease
  • Coronary heart disease risk in women
  • Coronary heart disease causes and development

Track 6:  Cardiac Remodeling or Ventricular Remodeling

Cardiac remodeling is defined as molecular and interstitial changes, manifested clinically by changes in size, mass, geometry and function of the heart under the stressful condition. Myocardial infarction and/or acute ischemia provoke profound changes in the properties of cardiac muscle. The response of the heart to sustained load increases, as in hypertension and aortic stenosis, results in an increase in muscle mass in overloaded chamber. We have included the session to help researchers in evaluating the different factors of cardiac remodeling and to further explore the underlying mechanism seeking the optimal therapeutic targets. Authors are welcome to submit experimental research articles. Topics of interest includes:

  • Cardiac Remodeling after Myocardial Infarction
  • Cardiac Remodeling in Hypertension
  • Cardiac remodeling in metabolic syndrome
  • Cardiac Remodeling in Heart Failure
  • Cardiac Remodeling in ischemia
  • Cardiac Remodeling in ventricular dysfunction
  • Cardiac Remodeling and Endothelial Function
  • Cardiac Remodeling in valve diseases
  • Blood vessels and perivascular fibrosis
  • Clinical Implications
  • Arrhythmias
  • Myocardial infarction complications
  • Pathophysiological Mechanisms of Cardiac Dysfunction
  • Pharmacological Treatment

Track 7:  Cardiac Diagnostic Test

Cardiac Diagnostic test It is the process to understand the complexity of disease, injury and abnormalities. The rising demand for efficient and rapid diagnostics of cardiovascular diseases, Cardiac Biomarker Testing is leading the market and expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. The other diagnostic tests that are being used to further understand and identify cardiovascular disease are:

  • Electrocardiogram
  • Echocardiogram
  • Coronary Arteriogram
  • Positron Emission Tomography
  • Thallium Scans or Myocardial Perfusion Scans
  • Electrophysiology Study
  • Cardiac Catheterization
  • Troponin-blood test

Troponin blood tests are widely used to help physicians detect heart attacks, test looks at a protein that comes directly from the heart and is found at elevated levels in the blood after heart muscle has been injured. As healthcare systems make a shift from treating symptoms of heart disease to preventing the onset of it, research now indicates that measuring a person's troponin levels using Abbott's High Sensitive Troponin-I blood test also can help predict a person's chances of having a cardiac event potentially years in advance when they show no signs or symptoms.

  • Electrocardiogram
  • Stress test
  • Transthoracic echocardiogram
  • Positron emission tomography (PET) scan
  • Thallium scans or myocardial perfusion scans
  • Holter monitor
  • Electrophysiology study
  • MRI of the heart
  • Cardiac CT scan

Track 8: Cardiothoracic Surgery Cardiometabolic Health- Diabetes, Obesity & Metabolism

Cardiometabolic health encompasses cardiovascular and metabolic diseases, including type 2 diabetes and metabolic syndrome. The risk factors include overweight/obesity, elevated blood pressure which can be modified by diet and lifestyle choices. Obesity which is a major factor of heart failure. This is a serious condition when your heart cannot pump enough blood to satisfy the needs of your body, a person is at increased risk of heart disease and stroke. One can reduce the risk by maintaining blood glucose levels, blood pressure and blood cholesterol levels. Stroke and coronary heart disease can be caused by the same problem - atherosclerosis.

The scientific goal of this track is to understand the underlying causes and pathophysiology of obesity, diabetes, and associated metabolic diseases, as well as pursuing effective and safe interventions and therapeutics.


Cardiothoracic surgery Cardiothoracic surgeons, cardiothoracic anesthesiologists, cardiologists, chest physicians, and allied health professionals are pleased to present their clinical and experimental advances in cardiac and thoracic surgery ensuring the best possible outcomes.

Topics of interest include surgical techniques, survival rates, surgical complications and their outcomes, pediatric conditions, Robotic and minimally invasive cardiac surgery, transplantations and clinical trials.

  • Adult cardiac surgery
  • General thoracic surgery
  • Congenital cardiac surgery
  • Heart and lung transplant surgery
  • Risks of cardiac surgery

Track 9:  Cardiac Toxicity

Cardiac toxicity The aim of this scientific session is clearly understanding the mechanism for cardiac toxicity and risk factors. The emergence of various targeted anticancer agents has led cardiotoxic potential. Cardiovascular complication from cancer therapy include heart failure, coronary artery disease, arrhythmias, QT prolongation, valvular disease, arterial hypertension, thromboembolic disease, and peripheral vascular disease. The field of cardiotoxicity induced by targeted drugs is rapidly expanding leading to the evolution of a new subspecialty of cardio-oncology to deal with the new health burden. Heart failure is one of the most dramatic clinical expressions of cardiotoxicity, and it may occur acutely or appear years after treatment. It is imperative for an oncologist to know the toxicity profile of newer agents to lower the risk against the benefit of these agents.

Track 10:  Cardiovascular Imaging-MRI, CT, Nuclear Medicine

Cardiovascular imaging- MRI can be used to measure how the heart uses oxygen for both healthy patients and those with heart disease. Currently, the diagnostic tests available to measure blood flow to the heart require injection of radioactive chemicals or contrast agents that change the MRI signal and detect the presence of disease.

We would like to welcome the researchers to bring out the new advance methods where MRI does not require needles and chemicals being injected into the body.

Cardiac nuclear medicine is useful in diagnosing and assessing coronary artery disease. It is also used to evaluate cardiomyopathy and identify possible damage to the heart from chemotherapy or radiotherapy. Nuclear medicine examinations provide unique information including details on the function and anatomy of structures that is often unattainable using other imaging procedures. Nuclear medicine procedures can be time consuming. It can take several hours to days for the radiotracer to accumulate in the area of interest, and imaging may take up to several hours to perform.

Further, Cardiovascular computed tomography (CCT) is a proven clinical utility in the diagnosis and management of coronary artery disease, in guiding structural heart disease intervention, and in the diagnosis and treatment of congenital heart disease.

As we know technology is changing rapidly in the field of healthcare leading to advancement in the diagnosis and treatment of patients with possible cardiovascular disease, our aim is to bring together experts to provide interactive session and networking.

  • Advanced imaging modalities
  • Noninvasive procedures- benefits vs Risks

Track 11: Pediatric Cardiac Nanomedicine

Pediatric cardiac Nanomedicine uses the nanotechnology in manipulating materials, structures and devices at the molecular level to diagnose, treat, cure damaged tissue or disease and to develop effective, therapeutic nanomedicine

Session goal will be an inventive and fortifying International gathering of Neonatologists, Pediatricians and Cardiologist to Share the Research Updates and enhance collaboration amongst members for scientific research and professional development and to maintain high standards of professional practices on Pediatrics and Cardiology, Cardiac Care.

  • Clinical applications in diagnostics, drug therapy and regenerative medicine
  • Effective therapeutic nanomedicine
  • Nanosurgery

Track 12: Cardiology Case Reports                                   

Cardiology case reports Euro Cardiology Congress 2020 intended to provide cardiology case reports for new developments in methodology and techniques featuring novel findings. This session is open to all the clinical cases such as various areas of heart related issues, cardiovascular medicine, cardiovascular diseases, myocardial infraction, atrial fibrillation, valvular heart diseases, cardiomyopathy, heart failure, coronary artery diseases, atherosclerosis, arrhythmias, angina, congenital heart diseases, pericardial disease, vascular diseases, hypertension, peripheral arterial disease, heart defects, pediatric cardiology, echocardiography, heart surgery and treatment.

  • Important clinical cases of recent occurrence
  • Rare medical cases and conditions
  • Latest methods of examination

Track 13: Myocarditis and Cardiomyopathies

Myocarditis and Cardiomyopathies Disorders characterized by structural and functional abnormalities of the myocardium. This group of pathological conditions includes dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and left ventricular noncompaction cardiomyopathy. All cardiomyopathies cause premature death from arrhythmia and progressive heart failure.

Interested researchers are welcome to submit their abstract aiming to contribute the important future research goals for precision medicine and individualized effective treatment.

  • Inflammation of the heart muscle wall
  • Possible causes of myocarditis- viral and bacterial infection
  • Cardiomyopathy
  • Preventive strategy for cardiomyopathy
  • Hypertrophic obstructive cardiomyopathy
  • Restrictive cardiomyopathy

Track 14: Pediatric Heart Transplantation

Pediatric Heart Transplantation With advances in surgical strategies and medical therapies, the outcomes for pediatric heart transplant recipients have continually improved. While significant post-transplant complications like rejection, infection, malignancy, and heart transplant remains a therapeutic option to improve both the quality and quantity of life for pediatric patients.

We are pleased to invite pediatric cardiac transplant surgeons and transplant cardiologists to help the young researchers advancing the understanding and management of Pediatric Heart Transplantation that will benefit both today's patients and transplant patients in the future.

  • Risk factors for mortality in Pediatric Heart Transplantation
  • Changing indications of Heart Transplantation
  • Alternative therapies and challenges
  • Current state of pediatric heart transplantation

Track 15: Cardiac Pharmacology

Cardiac pharmacology The pharmacological study that deals with Cardiac and Neuronal drugs. Cardiac or Cardiovascular pharmacology reveals the cardiac medicine activities in different heart diseases that include cardiac arrhythmias, hypertension, congestive heart failure, Angina and cardiomyopathy. The neuronal pharmacology concentrates on neurological disorders and their drug pharmacological activities. There is a physiological relation between these cardiac and neuropharmacology because almost every cardiac disorder is inter-dependent on the nervous system. The cardiac system is internally being controlled by sympathetic and parasympathetic nervous systems.


  1. Renin-Angiotensin-Aldosterone System
  2. Neural Control on Cardiovascular System
  3. Cardiovascular Drugs
  4. Pharmacokinetics
  5. Drug-Drug and Drug-Food Interactions
  6. Neurochemical Interactions
  7. Molecular and Behavioural Neuropharmacology
  • Pharmacotherapy for Cardiac Arrhythmias
  • Pharmacotherapy for Acute and Chronic Heart Failure
  • Drug Therapy for Systemic Hypertension
  • Anti-Ischemic Drug Therapy

Track 16: Molecular Cardiology

Molecular cardiology including heart attack, stroke, heart failure, and high blood pressure then translates these discoveries into new clinical strategies for diagnosis and therapy. As an emerging discipline, it  involves the study of molecular mechanisms of common cardiovascular diseases has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology.

  • Techniques for the mechanistic investigation and diagnosis
  • Transgenic techniques in cardiac research
  • Important discoveries that uncover the causes of congenital and acquired problems

Track 17: Current research on Cardiology - Future Medicine

Future medicine Research on prevention to diagnosis and treatment, the ongoing research includes pioneering the use of heart scanning in the early diagnosis of heart disease, development of Nuclear Cardiology techniques for the detection of heart disease, Drug development and evaluation of treatments used in heart disease, Identification of novel biological markers to predict the presence of heart disease, Analysis of ethnic and socio-economic differences in heart disease risk.

  • Role of electronics and digital technology
  • Will Artificial intelligence advance the cardiovascular field?
  • Novel drug discovery/development
  • New molecular approach to advancing cardiovascular therapy
  • Major technological advances in bioengineering in cardiology

Track 18: Cardio-Oncology and Nuclear Cardiology

Cardio-oncology and nuclear cardiology Cardiovascular implications of cancer therapy have led to the development of Cardio-Oncology which focuses on diagnosing, preventing and treating these complications. While a major focus of chemotherapy-related cardiac dysfunction has been on left ventricular ejection fraction, oncologic treatment can lead to cardiovascular pathology in a variety of ways. The use of multimodality imaging is essential to the care of these patients, with nuclear cardiology playing an important role.

Cardiologists, cardiac imaging specialists, cardio-oncologists and oncologists are welcome to submit their research providing understanding on how nuclear cardiac imaging may be used in the diagnosis, prevention and management of cardiovascular implications of cancer therapy.

  • Latest in nuclear cardiology
  • Novel molecular markers of pre-clinical cardiotoxicity
  • Modern oncologic therapies
  • Development of new anti-cancer drugs

Track 19: Cardiac Nursing: Acute and Chronic Cardiac Care

Cardiac nursing is a specialty focused on preventing and treating conditions, also an understanding of normal cardiac anatomy and physiology, keen assessment and monitoring skills, vast knowledge about cardiac disease and conditions, and ongoing education related to recommended prevention methods and treatment options. Clinical nurse specialists and nurse practitioners provides the comprehensive cardiovascular care for patients with acute and chronic heart. Major areas include:

Management of Cardiac Patients in Critical Care and Acute Care, Advanced Health Assessment, Clinical Prevention and Advanced Pathophysiology.

  • Discussion on the involvement of nurses in achieving an effective heart failure service
  • Management of Cardiac Patients in Critical Care and Acute Care
  • Advanced Health Assessment
  • Increase patient awareness and education of the condition and current management

Track 20: Lipidology & Preventive Cardiology

Lipidology The main goal is to understand the cause of dyslipidemia and primary prevention which can lead to heart and vascular problems such as heart attack, stroke and reduced circulation. To identify and reduce their risk factors through customized medical management, as well as nutrition and exercise counseling. Thus, the new era demands a more efficient and comprehensive approach to risk assessment and treatment with the mandate to detect and treat disease well before it becomes clinically apparent.

  • Assessment of individual risk and early initiation
  • Particularly severe or difficult to control elevations in cholesterol
  • Treatment plan to reduce the risk of cardiovascular events
  • Lipid research-implementing biochemical and molecular diagnosis techniques

Track 21: Hypertension and Healthcare       

Hypertension is the disorder where the blood pressure in the arteries is persistently raised at a constant rate. This is also called as high blood pressure or high vital sign or blood vessel cardiovascular disease. It can lead to severe health complications and increase the risk of heart disease, stroke, and sometimes death. This session primarily covers the various sorts of cardiovascular disease and their evaluation. Almost 90-95 % of cases are primary and the main cause behind it is the unhealthy lifestyle followed by excessive consumption of alcohol, salt, body weight etc. Remaining 5-10% of individuals suffer this due to thinning of kidney arteries, chronic kidney diseases, and endocrine disorder.  Assessment of cardiovascular disease primarily includes Confirmation of hypertension, Risk factors, Fundamental causes, organ injury & Indications and contraindications of medication. Hypertension could be a major threat issue for cardiopathy and stroke.

  • Causative Factors and Risk Assessment
  • Hypertension – Stress and Stroke
  • Advanced Treatment Approaches
  • Hypertensive Heart Disease
  • Causes of Cardiac Arrest Due to Hypertension

Track 22: Cardiovascular Engineering and Technology

Cardiovascular engineering & Technology It offers academic and industrial investigators a forum for the dissemination of research that utilizes engineering principles and methods to advance fundamental knowledge and technological solutions related to the cardiovascular system. Developing novel diagnostic and therapeutic approaches for cardiovascular diseases.

  • Advance implantable medical devices
  • Hemodynamics and tissue biomechanics
  • Functional imaging and surgical devices
  • Tissue engineering and regenerative medicine

Track 23: Catheterization and Cardiovascular Interventions

Catheterization It deals with the treatment of structural heart diseases with the catheter-based treatment. Cardiac catheterization is a procedure to examine heart muscle, valves or coronary (heart) arteries. A thin, hollow tube called a catheter is inserted into a large blood vessel that leads to your heart. Some heart disease treatments, such as coronary angioplasty and coronary stenting are done using cardiac catheterization. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery.

  • Risks of cardiac catheterization
  • Current research on effective procedures

Track 24:  Nephrocardiology

Nephrocardiology  Involves the clinical conditions that involves both heart and kidney. Understanding the latest findings regarding epidemiology and pathophysiology of combined heart and kidney diseases is the main goal of conference. Clinicians, researchers, and trainees in the fields of nephrology, cardiology, internal medicine and its subspecialties, hospital medicine, family medicine, pediatrics, emergency medicine, pulmonary and critical care medicine, geriatrics and anesthesiology, physicians and scientists, nurse practitioners and physician assistants are welcome to attend the conference.

  • Pulmonary Hypertension in Chronic Kidney Disease
  • Overview and Update on Uric Acid and Hyperuricemia

Track 25:  Electrocardiography

Electrocardiography Clinically used to monitor the electrical activity of the heart over time via electrodes placed on the skin of the chest. The method can identify aberrant activity caused by heart conditions, prime function in screening and diagnosis of cardiovascular diseases for better understanding, diagnosis, and treatment of cardiac diseases such as arrhythmias, altered activations, and ischemia.

  • Application of ECG diagnoses
  • Signal-averaged electrocardiogram
  • Transthoracic echocardiography




Market Analysis

Euro Cardiology Congress 2023 is a two-day programmer of presentations, panel discussions and interactive dialogue at the conference on leading the way in the research field of cardiology, vascular surgery & electrophysiology which is going to be held during May 22-23, 2023 at London, UK

Theme: Promoting the New Innovative thoughts In Cardiac Research

Importance & Scope:

Euro Cardiology Congress 2023 will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.

Growth of Cardiology Market:-

The Czech Republic also has some of the worst mortality figures for heart disease (IHD) and stroke (cerebrovascular accident or CVA). Death rates from heart disease are 260.4 per 100,000 populations & for stroke, the rate is 106.4 per 100,000 populations. The Czech Republic has more than halved its rate of case fatality after a heart attack, from 15% in 2001 to 6% in 2011.The prevalence of chronic heart disease among type 2 diabetes patients has fallen, from 40% in 2001 to below 30% in 2008. The country also has lower hospital admission rates for asthma and chronic obstructive pulmonary disease. The Czech Republic has initiated screening of blood pressure, cholesterol and other cardiovascular risk factors. But the cost-effectiveness of this programmer needs to be evaluated.

At the end of 1980s, the rapid transition from socialists economic to market economic caused further divergence in mortality. While in some countries like in Czech, rapid improvement in health condition were recorded and belatedly cardiovascular revolution took place. Since 1990s, among the Czech population, many changes and enormous improvements in cardiovascular health have occurred and resulted in more than 50% decline of CVD mortality rates; both due to changes in lifestyle, subsequent decrease in prevalence of risk factors and due to changes in healthcare. This trend diverted Czech from most of the Eastern European countries closer to Western European countries; however, the east–west mortality gap still persists in the case of CVDs.

It is mainly the mortality due to ischemic heart disease (IHD) (International Classification of Diseases which causes the differences. The level of IHD mortality in Czech (standardized death rate (SDR) in 2014 was 199 per 100 000 males, 115 per 100 000 females) is more than two times higher than in the European Union (EU) (SDR in 2014 was 96 per 100 000 males, 47 per 100 000 females). On contrary, the level of mortality due to stroke in Czech (SDR in 2014 was 61 per 100 000 males, 48 per 100 000 females) is only about 25% higher than in EU (SDR in 2014 was 49 per 100 000 males, 39 per 100 000 females). While the countries of Western Europe have passed the stage of cardiovascular revolution, the Czech population still remains far from having a ‘healthy lifestyle’, mainly due to a diet rich in saturated fat and salt and poor in fruit and vegetable intake, lack of physical activity leading to overweight and the prevalence of diabetes. Changes in the lifestyle of the Czech population are very slow compared with the extraordinary improvements in healthcare made during the 1990s.

Universities Associated with cardiology:

  • Charles University
  • Masaryk University
  • Czech Technical University
  • Plucky University Olomouc
  • University of Chemistry and Technology Prague
  • Brno University of Technology
  • Czech University of Life Sciences Prague
  • Ostrava University
  • Technical University of Ostrava
  • Tomas Bata University in Zlín
  • University of Pardubice
  • University of West Bohemia
  • Technical University of Liberec
  • University of South Bohemia (USB) in Ceske Budejovice

World Wide:

  • Medical University of Graz
  • Paracelsus Private Medical University of Salzburg
  • Universities Utrecht
  • University of Groningen
  • University of Leiden
  • Yerevan State Medical University
  • University College Roosevelt
  • Wageningen University
  • In Holland University of Applied Sciences
  • Saxion University of Applied Sciences
  • Vrije Universiteit Amsterdam
  • VU University Amsterdam
  • Academic Medical Centre
  • Amsterdam University of Applied Sciences
  • Wittenberg University of Applied Sciences
  • Tio University of Applied Sciences
  • EMGO⁺/Amsterdam Public Health research institute
  • University of Groningen
  • Netherlands Heart Institute
  • Harvard University
  • University of Oxford
  • University of Cambridge
  • Johns Hopkins University
  • University of Melbourne
  • University of Geneva
  • University of Bern
  • University of St Gallen (HSG) 
  • Stanford University

Hospitals Associated with the Cardiology:

  • Všeobecná fakultní nemocnice v Praze
  • Ústav pro Péči O Matku a Dítě
  • Nemocnice na Františku
  • Fakultní nemocnice v  Motole
  • Fakultní Nemocnice Královské Vinohrady
  • Gynekologicko-porodnická klinika VFN
  • Thomayerova nemocnice
  • Poliklinika I.P.Pavlova
  • Nemocnice na Bulovce
  • Psychiatrická léčebna Bohnice
  • Gynekologicko-porodnická klinika
  • Asklepion Medical Center
  • Poliklinika Parník Medical Centers
  • Mediscan Group
  • Poliklinika Mazurská
  • Moje Ambulance
  • Poliklinika Medifin


  • Johns Hopkins Hospital
  • Northwestern Memorial Hospital
  • Hospitals of the University of Pennsylvania-Penn Presbyterian
  • Mount Sinai Hospital
  • Sentara Norfolk General Hospital-Sentara Heart Hospital
  • Texas Heart Institute at Baylor St. Luke's Medical Center
  • Beaumont Hospital-Royal Oak
  • Minneapolis Heart Institute at Abbott Northwestern Hospital
  • Vanderbilt University Medical Center
  • Memorial Hermann-Texas Medical Center
  • University of Michigan Hospitals and Health Centers
  • Duke University Hospital
  • Brigham and Women's Hospital
  • Barnes-Jewish Hospital
  • UCLA Medical Center
  • Stanford Health Care-Stanford Hospital
  • Heart Hospital Baylor Plano
  • Cleveland Clinic
  • Mayo Clinic
  • New York-Presbyterian Hospital
  • Cedars-Sinai Medical Center
  • Massachusetts General Hospital
  • Houston Methodist Hospital
  • Loyola University Medical Center
  • NYU Langone Medical Center
  • UPMC Presbyterian Shadyside
  • Scripps La Jolla Hospitals
  • Ohio State University Wexner Medical Center
  • UCSF Medical Center
  • University of Alabama at Birmingham Hospital
  • University of Colorado Hospital

Industries Associated with Cardiology:

  • Pfizer pharmaceutical company 
  • Sanofi pharmaceutical company 
  • Merck pharmaceutical company 
  • AstraZeneca pharmaceutical company 
  • Gilead Sciences and health care
  • Johnson & Johnson pharmaceutical manufacturer company
  • Novartis pharmaceutical company ltd.
  • Roche pharmaceutical company 
  • Ocean Health Care Industries
  • Clinton Industries Inc

Cardiology Associations:

  • Czech Acute Cardiac care Association
  • Czech Association of Outpatient Cardiology
  • Czech Interventional Cardiology Association
  • Czech Heart Rhytmus  Association
  • Czech Heart Failure Association
  • Czech Cardiovascular Imaging Methods
  • Working Group on Valve Heart Disease
  • Working Group on Myocardial and Pericardiac Diseases
  • Working Group on Young Cardiologists
  • KardioTech
  • Working Group on Cardiovascular Pharmacotherapy
  • Working Group on Cardiovascular Rehabilitation
  • Working Group on Nurses in Cardiology
  • Working Group on Preventive Cardiology.

Target Audience:-

The professors, Researchers, Clinicians, Educators, Marketing and Students from academia in the study of Cardiology and Marketing.




To Collaborate Scientific Professionals around the World

Conference Date April 17-18, 2023

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Invasive and Non-Invasive Cardiology Current Trends in Cardiology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner